Mobile health applications in rheumatology: Could they improve our care and research?
Journal Title: International Journal of Clinical Rheumatology - Year 2019, Vol 14, Issue 1
Abstract
With>165,000 mobile health apps available on iTunes and Google Play mHealth is a rapidly growing field, which generated high expectations for the improvement of our health care. We identify two uses for mHealth in the field of rheumatology: A) aiding patient care and B) the systematic collection of data for scientific research. Currently, there is still a lack of evidence that mHealth will live up to the high promises. In this review we discuss the pros and cons of mHealth and the research that is needed to develop and validate mHealth to ensure high quality apps.
Authors and Affiliations
Maurits MP, Yuminaga H, Huizinga TWJ, Knevel R
Keywords
Related Articles
- EP ID EP614601
- DOI -
- Views 40
- Downloads 0
Application of treat-to-target principles in patients with early rheumatoid arthritis in routine clinical practice in Central-Eastern Europe
Objective: Understanding the extent to which treat-to-target (T2T) recommendations are applied by rheumatologists in patients with rheumatoid arthritis (RA) may identify gaps or issues in disease management. This study e...
Gender differences in ankylosing spondylitis patients: Relation to clinical characteristics, functional status and disease activity
Objective: To assess gender differences in Ankylosing Spondylitis (AS) patients regarding the clinical presentation, disease activity and functional status. Methods and findings: Forty AS patients; 21 males and 19 femal...
Improved clinical outcomes and physical activity in patients with rheumatoid arthritis treated with originator adalimumab in routine clinical practice
Background/Objective: We aimed at evaluating changes in habitual physical activity, disease activity and physical function following treatment with originator adalimumab (ADAORIG) in patients with Rheumatoid Arthritis (R...
Responsiveness to volume change of calcinosis cutis utilizing dual-energy computed tomography in a patient with diffuse cutaneous systemic sclerosis treated with alendronate
A 33-year-old pleasant Emirati lady presented to Cleveland Clinic Abu Dhabi with an established diagnosis of diffuse cutaneous systemic sclerosis and calcinosis cutis of 7 years duration from the first non-Raynaud’s dise...
Association of sarcoidosis and psoriasis: a difficult diagnosis
Sarcoidosis is a chronic multisystem disorder characterized by the formation of non caseating epithelioid cell granulomas affecting multiple organ systems. The role of the type 1 helper T (TH1) cells and type 17 helper T...